BI

BioTechne

TECH
NASDAQHealth Care
$56.03
USD
-0.14(-0.25%)
At close: Jun 16, 20:00 UTC

Open

$56.12

Prev. Close

$56.12

High

$56.18

Low

$55.95

Market Snapshot

Market Cap

$8.77B

P/E Ratio

80.0

EPS

1.00

Revenue

$1.2B

Why TECH moved

BioTechne continues to advance in the biotech sector, developing innovative solutions and maintaining a strong position amid increasing interest in AI-enhanced technologies and applications.

About

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. The company is headquartered in Minneapolis, Minnesota and currently employs 3,100 full-time employees. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers. This segment also manufactures and sells fully automated multiomic spatial biology instrumentation and advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use.

Recently from Cashu